MENU
INO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Inovio Pharmaceuticals (INO) Ownership - Who owns Inovio Pharmaceuticals?
Industry: @Medical Specialties
Profile
Industry
Medical Specialties
Address
660 West Germantown Pike
Phone
+1 267 440-4200
Employees
122
Web
https://www.inovio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
66.06M
P/E Ratio
N/A
Total Cash
84.8M
Projected Growth
N/A
Total Debt
12.45M
Revenue
203.41K
Risk (Beta)
1.76
Dividend Yield
N/A
Total Cash/Share
2.35
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
INO
Capitalization
66.1M
P/E Ratio
N/A
Risk (Beta)
1.76
Dividend Yield
N/A
Total Cash
84.8M
Total Cash/Share
2.35
Total Debt
12.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
203K
ROE
N/A
Book Value
73.5M
P/B Ratio
0.90
Cash Flow
N/A
Earnings
-4.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
26.1K
Current Ratio
3.88
Current Revenue Per Employee
825.92
Dividends Per Share - Security
N/A
EBITDA
-109.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-75.21
Shares Held By Institutions
74M
Shares Outstanding - Current
36.1M
Total Liabilities
33.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-70.098
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of synthetic vaccines and immune therapies for cancers and infectious diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
660 West Germantown Pike
Phone
+1 267 440-4200
Employees
122
Web
https://www.inovio.com